View our latest annual report (2023)
If so, please confirm below to proceed to our U.S. product page. If not, return to our homepage.
You are now leaving this website to visit another argenx website
This link will take you to a site maintained by a third party, which is responsible for its contents.
This link will take you to a site maintained by a third party, which is responsible for its contents.This website is intended for EU healthcare professionals only.
Please share just a few pieces of information so we can tailor the updates we send to you.
Not interested. Maybe later
Thank you for joining us on our journey to co-create potential therapies for people with severe autoimmune diseases. Together we discover.
Close
